# PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders

> **NCT00922428** · — · COMPLETED · sponsor: **Pascoe Pharmazeutische Praeparate GmbH** · enrollment: 1389 (actual)

## Conditions studied

- Rheumatic Diseases
- Arthralgia
- Myalgias/Myopathy
- Lumbago

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00922428
- **Lead sponsor:** Pascoe Pharmazeutische Praeparate GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 1389 (ACTUAL)
- **Last updated:** 2015-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922428, "PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00922428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*